Physician profile
Amanda Bright
NPI 1740665470
$5,506.70
in general payments reported to CMS, 2019-2025
35 companies · $1,910 in 2025
The $1,910 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $564 · 2023: $1,127 · 2024: $1,548 · 2025: $1,910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,585.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $655.10 | 2022-2025 | |
| Boston Scientific Corporation | $446.48 | 2023-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Ingevity+ |
| Amgen INC. | $399.69 | 2023-2025 | Repatha, Repatha |
| Aop Health US, LLC | $364.06 | 2025 | Rapiblyk |
| Silk Road Medical, INC. | $319.05 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| E.R. Squibb & Sons, L.L.C. | $313.50 | 2022-2025 | Camzyos, Eliquis |
| Getinge USA Sales, LLC | $294.82 | 2021-2024 | Vasoview Hemopro 2 |
| Abiomed | $292.49 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $271.58 | 2022-2025 | Wainua, Brilinta, Tagrisso |
| Abbott Laboratories | $254.92 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $231.50 | 2022-2025 | Verquvo |
| Atricure, INC. | $208.41 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Davol INC. | $163.60 | 2023 | Progel Applicator Spray Tips |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.73 | 2022-2024 | Jardiance |
| Philips North America LLC | $135.58 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Mechanical Tools, Extended Holter |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $122.73 | 2021 | |
| Novo Nordisk INC | $117.61 | 2024-2025 | Wegovy, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.81 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $91.27 | 2022-2023 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $66.64 | 2024 | Arcalyst |
| Pfizer INC. | $56.57 | 2022-2023 | |
| Haemonetics Corporation | $51.33 | 2022 | |
| Baxter Healthcare | $49.74 | 2024 | Perclot, Hillrom - Cardiac Ambulatory Monitor |
| Bridgebio Pharma, INC. | $43.59 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $39.68 | 2024 | |
| Scpharmaceuticals INC. | $35.52 | 2025 | |
| Sanofi-Aventis U.S. LLC | $35.00 | 2022 | |
| Humacyte Global, INC. | $30.34 | 2025 | Symvess |
| Teleflex LLC | $28.32 | 2023 | Manta |
| Lifenet Health | $28.00 | 2025 | Theragenesis Wound Matrix |
| Medtronic, INC. | $23.27 | 2025 | Endurant Iis |
| United Therapeutics Corporation | $22.72 | 2023 | Tyvaso, Orenitram |
| Kiniksa Pharmaceuticals, LTD. | $20.63 | 2023 | Arcalyst |
| Medicomp INC | $16.90 | 2024 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $14.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.